Channing Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Channing Capital Management, LLC

$3.76 Billion
Q3 2024

A detailed history of Channing Capital Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Channing Capital Management, LLC holds 50,607 shares of CRL stock, worth $8.18 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

50,607

Previous 50,409 0.39%

Holding current value

$8.18 Million

Previous $10.4 Million 4.26%

% of portfolio

0.27%

Previous 0.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $37,216 - $48,567	198 Added 0.39%	50,607 $9.97 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $73,268 - $95,399	-355 Reduced 0.7%	50,409 $10.4 Million
Q4 2023 Feb 06, 2024	BUY	$164.52 - $238.84 $198,246 - $287,802	1,205 Added 2.43%	50,764 $12 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $2.28 Million - $2.55 Million	11,717 Added 30.96%	49,559 $9.71 Million
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $2.1 Million - $2.4 Million	-11,412 Reduced 23.17%	37,842 $7.96 Million
Q1 2023 May 09, 2023	SELL	$191.89 - $259.92 $2.36 Million - $3.2 Million	-12,298 Reduced 19.98%	49,254 $9.94 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $77,267 - $98,027	-392 Reduced 0.63%	61,552 $13.4 Million
Q3 2022 Nov 08, 2022	BUY	$182.44 - $250.54 $5.82 Million - $8 Million	31,923 Added 106.34%	61,944 $12.2 Million
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $3.76 Million - $5.57 Million	-18,415 Reduced 38.02%	30,021 $6.42 Million
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $4.18 Million - $5.92 Million	16,355 Added 50.98%	48,436 $13.8 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $2.05 Million - $2.62 Million	5,834 Added 22.23%	32,081 $12.1 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $3.16 Million - $3.89 Million	-8,486 Reduced 24.43%	26,247 $10.8 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $1.94 Million - $2.45 Million	-6,595 Reduced 15.96%	34,733 $12.8 Million
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $1.58 Million - $1.89 Million	6,317 Added 18.04%	41,328 $12 Million
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $784,548 - $892,759	-3,534 Reduced 9.17%	35,011 $8.75 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $1.41 Million - $1.82 Million	-8,048 Reduced 17.27%	38,545 $8.73 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $27.4 Million - $43.7 Million	-230,180 Reduced 83.17%	46,593 $8.12 Million
Q1 2020 May 13, 2020	SELL	$98.9 - $178.34 $7.98 Million - $14.4 Million	-80,682 Reduced 22.57%	276,773 $34.9 Million
Q4 2019 Feb 12, 2020	SELL	$126.05 - $152.76 $1.88 Million - $2.27 Million	-14,888 Reduced 4.0%	357,455 $54.6 Million
Q3 2019 Nov 12, 2019	SELL	$125.07 - $143.67 $1.64 Million - $1.89 Million	-13,146 Reduced 3.41%	372,343 $49.3 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $9.6 Million - $11.6 Million	-77,781 Reduced 16.79%	385,489 $54.7 Million
Q1 2019 May 14, 2019	SELL	$104.82 - $146.73 $7.03 Million - $9.84 Million	-67,050 Reduced 12.64%	463,270 $67.3 Million
Q4 2018 Feb 12, 2019	SELL	$105.09 - $137.23 $14.3 Million - $18.7 Million	-136,295 Reduced 20.45%	530,320 $60 Million
Q3 2018 Nov 13, 2018	SELL	$112.11 - $134.54 $2.45 Million - $2.94 Million	-21,887 Reduced 3.18%	666,615 $89.7 Million
Q2 2018 Jul 20, 2018	SELL	$102.37 - $117.25 $1.34 Million - $1.53 Million	-13,081 Reduced 1.86%	688,502 $77.3 Million
Q1 2018 Apr 24, 2018	BUY	$98.19 - $115.2 $12.4 Million - $14.5 Million	126,169 Added 21.93%	701,583 $74.9 Million
Q4 2017 Feb 13, 2018	BUY	$100.43 - $118.09 $8.89 Million - $10.5 Million	88,549 Added 18.19%	575,414 $63 Million
Q3 2017 Oct 31, 2017	BUY	$96.72 - $109.26 $47.1 Million - $53.2 Million	486,865	486,865 $52.6 Million

Others Institutions Holding CRL

# of Institutions

692

Shares Held

52M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.22B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channing Capital Management, LLC with notifications on news.

Account

Channing Capital Management, LLC Charles River Laboratories International, Inc. Transaction History